BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16953991)

  • 1. Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.
    Pickett FA;
    J Dent Hyg; 2006; 80(3):10. PubMed ID: 16953991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate treatment: an orthodontic concern calling for a proactive approach.
    Zahrowski JJ
    Am J Orthod Dentofacial Orthop; 2007 Mar; 131(3):311-20. PubMed ID: 17346585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate-induced osteonecrosis of the jaw: a medical enigma?
    Siddiqi A; Payne AG; Zafar S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e1-8. PubMed ID: 19570696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonate associated osteonecrosis of the jaws--the role of the dentist in prevention and early diagnosis].
    Yarom N; Rachima H; Yahalom R
    Refuat Hapeh Vehashinayim (1993); 2006 Apr; 23(2):39-42, 67. PubMed ID: 16886875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonate-related osteonecrosis of the jaws--report of 2 cases and strategies on prevention and management.
    Wong YK; Cheng JC
    Quintessence Int; 2008 Mar; 39(3):195-201. PubMed ID: 18618033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.
    Ruggiero SL; Fantasia J; Carlson E
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):433-41. PubMed ID: 16997108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bisphosphonate-related osteonecrosis of the jaws].
    van der Waal I
    Ned Tijdschr Tandheelkd; 2012 Apr; 119(4):206-11. PubMed ID: 22567818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw.
    Arrain Y; Masud T
    Dent Update; 2008 May; 35(4):238-40, 242. PubMed ID: 18557500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.
    Patel V; McLeod NM; Rogers SN; Brennan PA
    Br J Oral Maxillofac Surg; 2011 Jun; 49(4):251-7. PubMed ID: 20605289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate-related osteonecrosis of the jaw.
    Feller L; Wood NH; Khammissa RA; Chikte UM; Bouckaert M; Lemmer J
    SADJ; 2011 Feb; 66(1):30-2. PubMed ID: 21510174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between osteonecrosis of the jaw and bisphosphonate treatment].
    Badel T; Keros J; Krapac L; Pavicin IS
    Arh Hig Rada Toksikol; 2010 Sep; 61(3):371-80. PubMed ID: 20860977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
    Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bisphosphonate-induced osteonecrosis of the jaws--a guide to diagnosis, therapy and prevention of BON in dental practice].
    Dannemann C; Grätz KW; Zwahlen RA
    Schweiz Monatsschr Zahnmed; 2008; 118(2):113-23. PubMed ID: 18361180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
    Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
    J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
    [No Abstract]   [Full Text] [Related]  

  • 16. Dental extractions in patient treated with intravenous bisphosphonates and risk of osteonecrosis of jaws: presentation of a preventive protocol and case series.
    Ferlito S; Liardo C; Puzzo S
    Minerva Stomatol; 2010; 59(11-12):593-601. PubMed ID: 21217623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis.
    Sarin J; DeRossi SS; Akintoye SO
    Oral Dis; 2008 Apr; 14(3):277-85. PubMed ID: 18336375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw.
    McLeod NM; Patel V; Kusanale A; Rogers SN; Brennan PA
    Br J Oral Maxillofac Surg; 2011 Jul; 49(5):335-42. PubMed ID: 20863603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the clinical implications of bisphosphonates in dentistry.
    Borromeo GL; Tsao CE; Darby IB; Ebeling PR
    Aust Dent J; 2011 Mar; 56(1):2-9. PubMed ID: 21332734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Focus: Drug-related osteonecrosis of the jaw].
    Schmouchkovitch A; Remaud M; Simon H; Herry H; Le Toux G; Boisramé S
    Presse Med; 2018 Jan; 47(1):19-33. PubMed ID: 29275972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.